US26817Q8868 - REIT

We assign a fundamental rating of **3** out of 10 to **DX**. **DX** was compared to 64 industry peers in the **Mortgage Real Estate Investment Trusts (REITs)"** industry. **DX** may be in some trouble as it scores bad on both profitability and health. **DX** has a decent growth rate and is not valued too expensively.

In the past year **DX** had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: **DX** reported negative net income in multiple years.

The **Return On Assets** of **DX** (**0.08%**) is worse than **65.63%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.08% | ||

ROE | 0.51% | ||

ROIC | N/A |

ROA(3y)2.01%

ROA(5y)1.63%

ROE(3y)8.41%

ROE(5y)4.42%

ROIC(3y)N/A

ROIC(5y)N/A

With a **Profit Margin** value of **1.92%**, **DX** is not doing good in the industry: **64.06%** of the companies in the same industry are doing better.

The **Operating Margin** and **Gross Margin** are not available for **DX** so they could not be analyzed.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | 1.92% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **DX** has been increased compared to 1 year ago.

Compared to 5 years ago, **DX** has more shares outstanding

Compared to 1 year ago, **DX** has a worse debt to assets ratio.

Based on the Altman-Z score of **-0.93**, we must say that **DX** is in the distress zone and has some risk of bankruptcy.

Looking at the **Debt to FCF ratio**, with a value of **193.62**, **DX** is doing worse than **64.06%** of the companies in the same industry.

A Debt/Equity ratio of **5.28** is on the high side and indicates that **DX** has dependencies on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 5.28 | ||

Debt/FCF | 193.62 | ||

Altman-Z | -0.93 |

ROIC/WACCN/A

WACC4.99%

With a **Current ratio** value of **0.06**, **DX** is not doing good in the industry: **76.56%** of the companies in the same industry are doing better.

A Quick Ratio of **0.06** indicates that **DX** may have some problems paying its short term obligations.

The **Quick ratio** of **DX** (**0.06**) is worse than **76.56%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.06 | ||

Quick Ratio | 0.06 |

The earnings per share for **DX** have decreased strongly by **-487.50%** in the last year.

The **Revenue** has grown by **466.46%** in the past year. This is a very strong growth!

The **Revenue** has been growing slightly by **3.79%** on average over the past years.

EPS 1Y (TTM)-487.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%55.56%

Revenue 1Y (TTM)466.46%

Revenue growth 3Y11.17%

Revenue growth 5Y3.79%

Sales Q2Q%143.92%

Based on estimates for the next years, **DX** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **49.30%** on average per year.

Based on estimates for the next years, **DX** will show a very strong growth in **Revenue**. The Revenue will grow by **154.64%** on average per year.

EPS Next Y65.31%

EPS Next 2Y73.84%

EPS Next 3Y49.3%

EPS Next 5YN/A

Revenue Next Year270.47%

Revenue Next 2Y227.65%

Revenue Next 3Y154.64%

Revenue Next 5YN/A

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

The **Price/Earnings Ratio** is negative for **DX**. In the last year negative earnings were reported.

Based on the **Price/Forward Earnings** ratio of **13.13**, the valuation of **DX** can be described as correct.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **DX** is on the same level as its industry peers.

When comparing the **Price/Forward Earnings** ratio of **DX** to the average of the S&P500 Index (**21.99**), we can say **DX** is valued slightly cheaper.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 13.13 |

The rest of the industry has a similar **Price/Free Cash Flow** ratio as **DX**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 33.45 | ||

EV/EBITDA | N/A |

A more expensive valuation may be justified as **DX**'s earnings are expected to grow with **49.30%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y73.84%

EPS Next 3Y49.3%

With a **Yearly Dividend Yield** of **12.43%**, **DX** is a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **12.14**, **DX** pays a bit more dividend than its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 12.43% |

The dividend of **DX** decreases each year by **-8.86%**.

Dividend Growth(5Y)-8.86%

Div Incr Years0

Div Non Decr Years2

DP1840.71%

EPS Next 2Y73.84%

EPS Next 3Y49.3%

**DYNEX CAPITAL INC**

NYSE:DX (9/13/2024, 8:10:21 PM)

After market: 12.75 0 (0%)**12.75**

**+0.2 (+1.59%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryMortgage Real Estate Investment Trusts (REITs)"

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap952.55M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 12.43% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 13.13 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.08% | ||

ROE | 0.51% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | 1.92% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.04

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 5.28 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.06 | ||

Quick Ratio | 0.06 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-487.5%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y65.31%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)466.46%

Revenue growth 3Y11.17%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y